This page shows the latest cardiovascular drug news and features for those working in and with pharma, biotech and healthcare.
The investigational drug candidate met all primary and secondary endpoints in the phase 3 study, BMS said in a statement. ... address the underlying molecular defect of the disease,” said Roland Chen, senior vice president, cardiovascular development,
Previously, Novartis had attempted to expand the use of canakinumab as a potential cardiovascular treatment. ... This attempt failed to generate success, with Novartis pulling an EU filing for the drug in the cardiovascular setting in 2018.
In December 2019, the US Food and Drug Administration (FDA) approved the drug with the brand name Vascepa, also to reduce the risk of cardiovascular events in high-risk patients. ... At that time, Vascepa became the first FDA-approved drug to reduce
Boehringer Ingelheim and Eli Lilly’s heart failure drug Jardiance reduced the risk of cardiovascular death or hospitalisation due to heart failure in adult patients with and without diabetes – an important ... In March, the US Food and Drug
Even though the drug reduced hospitalisation, the difference in cardiovascular death and all-cause mortality between the groups was not significantly different. ... The New Drug Application (NDA) filed for vericiguat is aiming for approval as a treatment
It became the first US Food and Drug Administration (FDA)-approved drug to reduce cardiovascular risk in patients with elevated triglyceride levels as an add-on to maximally tolerated statin therapy. ... treating indicated patients at high risk of
More from news
Approximately 2 fully matching, plus 100 partially matching documents found.
For example, a drug being used for cardiovascular disease might be found to have useful qualities for neurological diseases. ... We’re already seeing evidence of how AI can positively impact drug discovery.
Looking to the second half of this year and Sanofi is aiming for a Q3 launch for its new PCSK9 cardiovascular disease management drug Praluent (alirocumab), which comes from its collaboration ... centric means that you need to think about your patients
Several obstacles stand in the way of the uptake of Tresiba in Europe, including the decision from the US FDA to request more data from Novo Nordisk regarding the drug's ... cardiovascular safety before it can be approved.
In return for granting Merck a global exclusive licence to its cardiovascular drug candidates, Theravance will receive $153m in R&D funding and milestone payments, including a $5m upfront payment and ... and manufacturing partner. Quillivant XR is based
These are Benlysta (belimumab), an antibody approved for the treatment of lupus; darapladib, a phase III small molecule drug for the treatment of cardiovascular disease; and albiglutide, an albumin-fusion protein ... 168. Vestiq / BioAlliance (a). Licence
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
Alex arrives here with first class operational and clinical development expertise in novel drug therapies, targeting cardiovascular and metabolic disease and kidney disease amongst others. ... A cardiologist with over 16 years experience of drug
AstraZeneca's chief executive, Pascal Soriot, will take over the job of late-stage drug development on an interim basis, according to news reports. . ... Meanwhile Elisabeth Björk, an associate professor of medicine at Uppsala university and leads
Cardiovascular specialist Milestone Pharmaceuticals has appointed experienced pharma researcher Dr Francis Plat as its new chief medical officer. ... Milestone's CEO Philippe Douville said: "Dr Plat is the perfect candidate for our development program
He also served for four years as the industry representative to the FDA's Cardiovascular and renal Drug Products Advisory Committee. ... By translating the groundbreaking science of the founding investigators into effective, disease modifying treatments,
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
For example, drug-drug interaction studies may enable those who currently take prescribed medicine to take part. ... For example, a clinical trial investigating a cardiovascular drug would specifically seek to enrol participants with risk factors for
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...